However, there are puzzling data showing that IL-17, in addition to its proinflammatory properties, can delay the development of obesity by inhibiting precursor transcription factors and adipokines and acting on preadipocytes to inhibit adipogenesis and differentiation [32]. Here, IL17A is linked to obesity disorder.